Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival-Reference-Cited by-同舟云学术

Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival

Published:2018-04-06 Issue:11 Volume:110 Page:1248-1258
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Herr Megan M¹,Schonfeld Sara J¹,Dores Graça M¹,Withrow Diana R¹,Tucker Margaret A¹,Curtis Rochelle E¹,Morton Lindsay M¹

Affiliation:

1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD

Funder

Division of Cancer Epidemiology and Genetics, National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/110/11/1248/26555220/djy052.pdf

Reference65 articles.

1. Leukemia and cancer in the same patient;Gunz;Cancer.,1965

2. The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma;Berg;J Natl Cancer Inst.,1967

3. Subsequent cancer in patients with chronic lymphocytic leukemia—a possible immunologic mechanism;Greene;J Natl Cancer Inst.,1978

4. Association of malignant melanoma and malignant lymphoma;Tashima;Lancet.,1973

5. Evidence for an association between cutaneous melanoma and non‐Hodgkin lymphoma;Goggins;Cancer.,2001

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Melanoma and CLL co-occurrence and survival: role of KC history;BMC Cancer;2023-11-09

3. Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies;European Journal of Cancer;2023-06

4. Multiple primary malignancies in 788 Chinese patients with diffuse large B‐cell lymphoma;Cancer Medicine;2023-05-21

5. Treatment response and recurrence of conjunctival melanoma with orbital invasion treated with immune checkpoint inhibitors: case report and literature review;Orbit;2023-04-13